Invesaro

Stocks TRSG Financial statements

Financial statements

Tungray Technologies Inc financial statements

Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data Tungray Technologies Inc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2021FY2023FY2023FY2024FY2025
Revenue17.516.314.412.815.6
Cost of revenue8.217.077.657.218.45
Gross profit9.269.276.715.67.17
Research and development0.670.830.791.060.98
General and administrative3.324.544.44.595.48
Operating expenses4.385.985.616.257.41
Operating income4.883.281.1-0.66-0.24
Interest expense0.140.210.070.110.07
Other non-operating income0.130.190.190.360.2
Pre-tax income5.013.471.29-0.29-0.04
Income tax0.71-0.630.540.280.13
Net income to minority interests-0-0.01-0.1-0.09-0.16
Net income4.32.850.76-0.57-0.17
EBITDA5.093.461.35-0.290.15
EPS, basic0.290.190.06
EPS, diluted0.290.190.06
Shares, basic (weighted)151515
Shares, diluted (weighted)151515

Balance sheet

FY2021FY2023FY2023FY2024FY2025
Cash and equivalents11.313.110.88.976.62
Receivables0.10.322.393.48
Inventory1.42.282.213.35
Other current assets0.0303.823
Total current assets17.918.519.818.7
Property, plant and equipment6.456.336.177.13
Lease right-of-use assets0.670.711.411.13
Intangible assets0.0300.060.24
Long-term investments0.220.210.212.27
Total assets2627.129.929.5
Accounts payable1.11.051.361.86
Accrued liabilities0.991.291.451.91
Deferred revenue1.854.016.123.15
Total current liabilities8.339.0310.69.65
Lease liabilities0.010.690.55
Other non-current liabilities2.862.3
Total liabilities11.211.312.611.5
Paid-in capital0.330.333.143.1
Retained earnings14.715.515.115
Other comprehensive income-0.4-0.28-1.01-0.02
Shareholders' equity14.815.717.318
Minority interests-0.01-0.11-0.16-0.33
Total equity12.214.815.717.418.4
Total liabilities and equity2627.129.929.5

Cash flow statement

FY2021FY2023FY2023FY2024FY2025
Net income4.32.840.76-0.57-0.17
Depreciation and amortization0.210.170.250.370.39
Deferred income tax-0.03-0.010.0700
Change in receivables-0.87-0.65-1.371.02-0.98
Change in inventory-0.510.3-0.91-0.12-1.04
Change in payables0.55-0.39-0.030.350.44
Cash from operations5.993.640.45-0.81-3.05
Capital expenditures-0.21-0.15-0.04-0.45-0.8
Cash from investing-1.01-0.1-0.08-2.78-1.64
Dividends paid-1.65-1.28-0.52
Cash from financing-0.01-1.4-2.812.791.31
Net change in cash5.241.79-2.33-1.33-2.83
Free cash flow5.783.490.41-1.26-3.85
Interest paid0.190.160.090.070.07
Income taxes paid0.270.390.660.750.18

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $1.38 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin45.9%Gross profit / revenue.
Operating margin-1.5%Operating income / revenue.
EBITDA margin0.9%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-0.3%Pre-tax income / revenue.
Net margin-1.1%Net income / revenue.
FCF margin-24.6%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-19.5%Cash from operations / revenue.
Return on equity (ROE)-1.0%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-0.6%Net income / average total assets.
Return on invested capital (ROIC)-1.9%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue6.2%Research and development expense / revenue.
Capex / revenue5.1%Capital expenditures / revenue.
D&A / revenue2.5%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y22.0%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-1.5%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y28.1%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-8.2%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 3y-65.2%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y4.5%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y6.7%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y-1.3%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y4.3%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.94xCurrent assets / current liabilities.
Quick ratio1.05x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.69x(Cash + short-term investments) / current liabilities.
Liabilities / assets38.9%Total liabilities / total assets.
Interest coverage-3.65xOperating income / interest expense.
Working capital$9.1MCurrent assets - current liabilities.
Goodwill and intangibles / assets0.8%(Goodwill + intangible assets) / total assets.
Tangible book value$17.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.53xRevenue / average total assets.
Fixed asset turnover2.35xRevenue / average property, plant and equipment.
Inventory turnover3.04xCost of revenue / average inventory.
Days inventory120 days365 x average inventory / cost of revenue.
Receivables turnover5.32xRevenue / average receivables.
Days sales outstanding69 days365 x average receivables / revenue.
Days payables69 days365 x average accounts payable / cost of revenue.
Cash conversion cycle119 daysDays inventory + days sales outstanding - days payables.

Valuation

MetricValueHow it is calculated
Market cap$22.6MShare price x shares outstanding.
Enterprise value$16.0MMarket cap + total debt - cash - short-term investments.
P/S1.45xMarket cap / revenue.
P/B1.25xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.27xMarket cap / tangible book value, when positive.
EV/Sales1.02xEnterprise value / revenue.
EV/EBITDA110xEnterprise value / EBITDA, when both are positive.
FCF yield-17.0%Free cash flow / market cap.
Earnings yield-0.8%Net income / market cap (the inverse of P/E).
What was Tungray Technologies Inc's revenue in fiscal 2025?

Tungray Technologies Inc reported revenue of $15.6M for fiscal 2025, 22% higher than the year before.

Was Tungray Technologies Inc profitable in fiscal 2025?

No. It reported a net loss of $170.3K.

How much free cash flow did Tungray Technologies Inc generate in fiscal 2025?

Cash from operations of $3.0M minus capital expenditures of $799.3K left free cash flow of -$3.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Tungray Technologies Inc